Alprostadil ( DrugBank: Alprostadil )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1
70	広範脊柱管狭窄症	1

51. 全身性強皮症

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02228850 (ClinicalTrials.gov)	November 2014	20/8/2014	Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Pheno ...	A Phase 2a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of the Acute Peripheral Vasc ...	Raynaud's Phenomenon Secondary to Systemic Sclerosis	Drug: Alprostadil;Other: Placebo	NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)	NULL	Completed	18 Years	79 Years	Both	35	Phase 2	United States

臨床試験数 : 96 / 薬物数 : 203 - (DrugBank : 60) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 89

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000005959	2010/11/01	12/07/2011	Prospective clinical study of the therapeutic effects of prostaglandin in patients with combined lum ...		Patients with combined lumbar spinal stenosis and arteriosclerosis obliterans	Prostaglandin for injection (alprostadil) group: 60 mcg of prostaglandin for injection is intravenou ...	Tokai University HospitalDepartment of Orthopaedic Surgery	NULL	Complete: follow-up continuing	20years-old	Not applicable	Male and Female	300	Not selected	Japan